Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $3.2 million.

  • Inhibrx Biosciences' Interest Expenses changed N/A to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 5850.14%. This contributed to the annual value of $13.5 million for FY2024, which is 5762.88% down from last year.
  • Inhibrx Biosciences' Interest Expenses amounted to $3.2 million in Q3 2025.
  • Inhibrx Biosciences' Interest Expenses' 5-year high stood at $8.2 million during Q4 2023, with a 5-year trough of $2.7 million in Q1 2025.
  • In the last 3 years, Inhibrx Biosciences' Interest Expenses had a median value of $6.6 million in 2023 and averaged $5.8 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 3218.22% in 2024, then crashed by 6692.5% in 2025.
  • Quarter analysis of 3 years shows Inhibrx Biosciences' Interest Expenses stood at $8.2 million in 2023, then plummeted by 34.8% to $5.4 million in 2024, then tumbled by 40.66% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $3.1 million for Q2 2025, and $2.7 million during Q1 2025.